Trial Profile

A Phase 2 Clinical Trial to Assess the Safety and Observe the Potential Benefit of TTHX1114 Delivered Via Intra-Cameral (IC) Injection

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 10 Nov 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs TTHX 1114 (Primary)
Indications Corneal disorders
Focus Expanded access; Therapeutic Use
Acronyms OPTIC
Sponsors Trefoil Therapeutics

Most Recent Events

06 Nov 2023 Status changed from recruiting to completed.
25 Oct 2021 Status changed from not yet recruiting to recruiting.
06 Oct 2021 Planned End Date changed from 30 Apr 2023 to 30 Dec 2023.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com